N/A
N=50
TUI 3D in Diagnosis of Placenta Accreta: Comparison With Gray-scale and Color Doppler Techniques
Placenta Accreta
Bottom Line
View on ClinicalTrials.gov: NCT02712099 ↗Enrolled (actual)
50
Serious AEs
0.0%
Results posted
Apr 2017
Primary outcome: Primary: Loss of the Retro Placental Sonolucent Zone by 2D Grayscale Ultrasonography — 12; 19 participants
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Adult · 20+ yrs
- Sex
- Female
- Sponsor
- Ain Shams University
- Primary completion
- Feb 2016
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Loss of the Retro Placental Sonolucent Zone by 2D Grayscale Ultrasonography |
12; 19 | — |
| PRIMARY Abnormal Placental Lacunae by 2D Grayscale Ultrasonography |
19; 15 | — |
| SECONDARY Crowded Vessels Over Peripheral Sub-placental Zone by Power Doppler Ultrasonography |
8; 18 | — |
| SECONDARY Abnormal Placental Lacunae by Power Doppler Ultrasonography |
20; 13 | — |
| SECONDARY Crowded Vessels Over Peripheral Sub-placental Zone by 3D Tomographic Ultrasound Imaging (TUI) |
7; 18 | — |
| SECONDARY Abnormal Placental Lacunae by 3D Tomographic Ultrasound Imaging (TUI) |
19; 13 | — |
Summary
The purpose of this study is to evaluate the potential of the 3 D TUI view in diagnosis of morbidly adherent placenta in comparison to 2D grayscale, color Doppler and intraoperative findings.
Eligibility Criteria
Inclusion Criteria
- History of previous cesarean section or hysterotomy.
- Placenta previa with its lower edge covering the scar of previous cesarean section
- From 28 wks to Full term.
Exclusion Criteria
- Multiple pregnancies.
- Medical disorder as diabetes mellitus, hypertension.
- Obese patients. BMI > 30
- Intrauterine growth retardation.
Data sourced from ClinicalTrials.gov (NCT02712099). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.